VEGFB and ovarian cancer: Vecchione et al. [33] found that miR-484 was associated with chemoresistance in ovarian cancer and determined that the sensitive phenotype is a result of modulation of the tumor vasculature through the regulation of the VEGFB and VEGFR2 pathways, rather than through the inhibition of apoptosis.